These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26762419)

  • 1. In vitro and ex vivo corneal penetration and absorption models.
    Agarwal P; Rupenthal ID
    Drug Deliv Transl Res; 2016 Dec; 6(6):634-647. PubMed ID: 26762419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro cell culture models to study the corneal drug absorption.
    Reichl S; Kölln C; Hahne M; Verstraelen J
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):559-78. PubMed ID: 21381983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.
    Reichl S
    J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid assessment of ocular drug delivery in a novel ex vivo corneal model.
    Begum G; Leigh T; Courtie E; Moakes R; Butt G; Ahmed Z; Rauz S; Logan A; Blanch RJ
    Sci Rep; 2020 Jul; 10(1):11754. PubMed ID: 32678110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance-associated protein (MRP1, 2, 4 and 5) expression in human corneal cell culture models and animal corneal tissue.
    Verstraelen J; Reichl S
    Mol Pharm; 2014 Jul; 11(7):2160-71. PubMed ID: 24456047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies.
    Verstraelen J; Reichl S
    Int J Pharm; 2013 Jan; 441(1-2):765-75. PubMed ID: 23069916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
    Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
    J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation.
    Pescina S; Govoni P; Potenza A; Padula C; Santi P; Nicoli S
    J Pharm Sci; 2015 Jan; 104(1):63-71. PubMed ID: 25394188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal cell culture models: a tool to study corneal drug absorption.
    Dey S
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):529-32. PubMed ID: 21500964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.
    Sharma C; Biswas NR; Ojha S; Velpandian T
    Drug Des Devel Ther; 2016; 10():811-23. PubMed ID: 26955263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pH and penetration enhancers on cysteamine stability and trans-corneal transport.
    Pescina S; Carra F; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2016 Oct; 107():171-9. PubMed ID: 27395395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular bioavailability of ciprofloxacin in sustained release formulations.
    Ke TL; Cagle G; Schlech B; Lorenzetti OJ; Mattern J
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):555-63. PubMed ID: 11777179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.
    Kaluzhny Y; Klausner M
    In Vitro Cell Dev Biol Anim; 2021 Feb; 57(2):207-237. PubMed ID: 33544359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culture model of human corneal epithelium for prediction of ocular drug absorption.
    Toropainen E; Ranta VP; Talvitie A; Suhonen P; Urtti A
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2942-8. PubMed ID: 11687540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of combined menthol and borneol on fluconazole permeation through the cornea ex vivo.
    Liu J; Fu S; Wei N; Hou Y; Zhang X; Cui H
    Eur J Pharmacol; 2012 Aug; 688(1-3):1-5. PubMed ID: 22200629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
    Rathod LV; Kapadia R; Sawant KK
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():529-540. PubMed ID: 27987741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas.
    Reichl S; Döhring S; Bednarz J; Müller-Goymann CC
    Eur J Pharm Biopharm; 2005 Jul; 60(2):305-8. PubMed ID: 15939241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.